Stanford Stroke Center News and Events
May 3, 2017: Stanford Health Care announced that it has been recertified by The Joint Commission as an Advanced Comprehensive Stroke Center, a prestigious designation reserved for institutions with specific abilities to receive and treat the most complex stroke cases.
Stanford Stroke Doctors Advance Brain Imaging Techniques and Treatments
In a multicenter study led by Stanford researchers, the number of stroke patients who died or required confinement to nursing homes was nearly cut in half, the biggest improvement seen in any stroke-related trial to date.
Advanced brain imaging technology may give doctors an additional 10 hours or more to respond to some strokes, researchers said Wednesday, a development that may soon bring major changes to the way hospitals treat one of the leading causes of disability and death.
Advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed, according to a new study.
We conducted a multicenter, randomized, open-label trial, with blinded outcome assessment, of thrombectomy in patients 6 to 16 hours after they were last known to be well and who had remaining ischemic brain tissue that was not yet infarcted.
Clinical trial shows broader benefits of acute-stroke therapy iSchemaView RAPID software plays central role in success
DEFUSE 3, a 38-center clinical trial sponsored by the National Institutes of Health and led by Stanford researchers, has shown that far more people than previously thought can benefit from existing emergency treatments for acute ischemic stroke.
Stanford Health Care announced that it has been recertified by The Joint Commission as an Advanced Comprehensive Stroke Center, a prestigious designation reserved for institutions with specific abilities to receive and treat the most complex stroke cases.
Treatment for stroke is determined by the stopwatch. Missing the few hours that are the window of opportunity between stroke onset and the time of diagnosis make many patients ineligible for reperfusion therapy
Why is the risk for developing dementia doubled for as much as a decade after stroke? A new study suggests the answer may be B cells.
Study ties immune cells to delayed onset of post-stroke dementia
Researchers say that the appearance in the brain of a type of immune cell has been implicated in delayed dementia in mice and humans who have suffered a stroke.
The Weirdness of Boxes
In this Brain Game, Jason Silva and Dr. Allison Okamura show us how conflicting information can trick our senses into believing lies.
Public policies for addiction, smarter prosthetics and stroke among the Big Ideas tackled by Stanford neuroscientists
Brain research that improves policies for treating drug addiction is one of seven Big Ideas that will become new priorities for the Stanford Neurosciences Institute. These new interdisciplinary teams span schools and disciplines to tackle critical challenges in brain research.
With financial support from the Big Ideas in Neuroscience program, Maarten Lansberg, MD, PhD, and Marion Buckwalter, MD, PhD, have merged their basic science and clinical backgrounds, pulled in experts from across Stanford and built a collaborative network of brain power to tackle this essential question: Why do some patients recover better from stroke while others do not? The Stroke Collaborative Action Network, or SCAN, was developed to understand the mechanisms of stroke recovery and to enhance recovery through new treatments.
SHC Pride Celebrates the Advanced Comprehensive Stroke Center
Rebuilding the Brain After Stroke, World Economic Forum
Dr. Buckwalter spoke about the SCAN project at the World Economic Forum in January 2015. She talked about the importance of stroke as a global health problem and the importance of collaboration between disciplines to solve the problem of how stroke recovery works, and described how SCAN scientists are working together to develop treatments for stroke survivors.